APA (7th ed.) Citation

CH, M., Z, G., RN, S., TP, M., M, R., A, Z., . . . JH, N. (2025). Does the 1: 1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium. The American surgeon, 91(9), 1484. https://doi.org/10.1177/00031348251358431

Chicago Style (17th ed.) Citation

CH, Meyer, et al. "Does the 1: 1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive Transfusion Multi-Center Trial) Consortium." The American Surgeon 91, no. 9 (2025): 1484. https://doi.org/10.1177/00031348251358431.

MLA (9th ed.) Citation

CH, Meyer, et al. "Does the 1: 1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive Transfusion Multi-Center Trial) Consortium." The American Surgeon, vol. 91, no. 9, 2025, p. 1484, https://doi.org/10.1177/00031348251358431.